Melissa Fleury

Person

Brisbane, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Neprilysin inhibitors
- Patent number 12,016,835
- Issue date Jun 25, 2024
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neprilysin inhibitors
- Patent number 11,919,888
- Issue date Mar 5, 2024
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neprilysin inhibitors
- Patent number 11,851,443
- Issue date Dec 26, 2023
- Theravance Biopharma R&D IP, LLC
- Roland Gendron
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-...
- Patent number 11,718,591
- Issue date Aug 8, 2023
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 11,718,616
- Issue date Aug 8, 2023
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 11,642,332
- Issue date May 9, 2023
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Grant
Neprilysin inhibitors
- Patent number 11,634,413
- Issue date Apr 25, 2023
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neprilysin inhibitors
- Patent number 11,547,687
- Issue date Jan 10, 2023
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 11,299,492
- Issue date Apr 12, 2022
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neprilysin inhibitors
- Patent number 11,261,197
- Issue date Mar 1, 2022
- Theravance Biopharma R&D IP, LLC
- Roland Gendron
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-...
- Patent number 11,230,536
- Issue date Jan 25, 2022
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neprilysin inhibitors
- Patent number 11,174,219
- Issue date Nov 16, 2021
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neprilysin inhibitors
- Patent number 11,124,502
- Issue date Sep 21, 2021
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidine compounds as JAK kinase inhibitors
- Patent number 11,110,095
- Issue date Sep 7, 2021
- Theravance Biopharma R&D IP, LLC
- Ryan Hudson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 11,033,533
- Issue date Jun 15, 2021
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and β2 adre...
- Patent number 10,836,744
- Issue date Nov 17, 2020
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neprilysin inhibitors
- Patent number 10,829,438
- Issue date Nov 10, 2020
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-...
- Patent number 10,752,599
- Issue date Aug 25, 2020
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neprilysin inhibitors
- Patent number 10,744,104
- Issue date Aug 18, 2020
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and Beta2 a...
- Patent number 10,590,107
- Issue date Mar 17, 2020
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neprilysin inhibitors
- Patent number 10,570,120
- Issue date Feb 25, 2020
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 10,548,879
- Issue date Feb 4, 2020
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 10,526,330
- Issue date Jan 7, 2020
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(e...
- Patent number 10,472,335
- Issue date Nov 12, 2019
- Theravance Biopharma R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and β2 adre...
- Patent number 10,358,433
- Issue date Jul 23, 2019
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neprilysin inhibitors
- Patent number 10,315,984
- Issue date Jun 11, 2019
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neprilysin inhibitors
- Patent number 10,189,823
- Issue date Jan 29, 2019
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...
- Patent number 10,172,834
- Issue date Jan 8, 2019
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Grant
Diamide compounds having muscarinic receptor antagonis and beta2 ad...
- Patent number 10,138,220
- Issue date Nov 27, 2018
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neprilysin inhibitors
- Patent number 10,130,642
- Issue date Nov 20, 2018
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...
- Publication number 20240327360
- Publication date Oct 3, 2024
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20230312537
- Publication date Oct 5, 2023
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20230285340
- Publication date Sep 14, 2023
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE
- Publication number 20220306624
- Publication date Sep 29, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20220298173
- Publication date Sep 22, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- Roland Gendron
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...
- Publication number 20220242836
- Publication date Aug 4, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20220106300
- Publication date Apr 7, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...
- Publication number 20210401808
- Publication date Dec 30, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20210155576
- Publication date May 27, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE
- Publication number 20210130351
- Publication date May 6, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20210079017
- Publication date Mar 18, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Roland Gendron
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...
- Publication number 20210061776
- Publication date Mar 4, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20210059966
- Publication date Mar 4, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...
- Publication number 20210024493
- Publication date Jan 28, 2021
- Theravance Respiratory Company, LLC
- Adam D. HUGHES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20200283422
- Publication date Sep 10, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...
- Publication number 20200281900
- Publication date Sep 10, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Application
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...
- Publication number 20200165223
- Publication date May 28, 2020
- Theravance Respiratory Company, LLC
- Adam D. HUGHES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...
- Publication number 20200157061
- Publication date May 21, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIMIDINE COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20200046709
- Publication date Feb 13, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Ryan Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20200017436
- Publication date Jan 16, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...
- Publication number 20190300504
- Publication date Oct 3, 2019
- Theravance Respiratory Company, LLC
- Adam D. HUGHES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20190276442
- Publication date Sep 12, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...
- Publication number 20190269659
- Publication date Sep 5, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- C30 - CRYSTAL GROWTH
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20190262297
- Publication date Aug 29, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
- Publication number 20190106420
- Publication date Apr 11, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...
- Publication number 20190047984
- Publication date Feb 14, 2019
- Theravance Respiratory Company, LLC
- Adam D. HUGHES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE(2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENY]-4-YL)-2-(E...
- Publication number 20190002416
- Publication date Jan 3, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20180327350
- Publication date Nov 15, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20180237423
- Publication date Aug 23, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...
- Publication number 20180228774
- Publication date Aug 16, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Melissa Fleury

Person

Patents Grantslast 30 patents

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-...

JAK kinase inhibitor compounds for treatment of respiratory disease

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

Neprilysin inhibitors

Neprilysin inhibitors

JAK kinase inhibitor compounds for treatment of respiratory disease

Neprilysin inhibitors

Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-...

Neprilysin inhibitors

Neprilysin inhibitors

Pyrimidine compounds as JAK kinase inhibitors

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

Diamide compounds having muscarinic receptor antagonist and β2 adre...

Neprilysin inhibitors

Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-...

Neprilysin inhibitors

Diamide compounds having muscarinic receptor antagonist and Beta2 a...

Neprilysin inhibitors

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

JAK kinase inhibitor compounds for treatment of respiratory disease

Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(e...

Diamide compounds having muscarinic receptor antagonist and β2 adre...

Neprilysin inhibitors

Neprilysin inhibitors

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyl...

Diamide compounds having muscarinic receptor antagonis and beta2 ad...

Neprilysin inhibitors

Patents Applicationslast 30 patents

CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...

NEPRILYSIN INHIBITORS

NEPRILYSIN INHIBITORS

JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE

NEPRILYSIN INHIBITORS

CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...

NEPRILYSIN INHIBITORS

(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...

NEPRILYSIN INHIBITORS

JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE

NEPRILYSIN INHIBITORS

CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...

NEPRILYSIN INHIBITORS

Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...

NEPRILYSIN INHIBITORS

(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...

Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...

CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-...

PYRIMIDINE COMPOUNDS AS JAK KINASE INHIBITORS

NEPRILYSIN INHIBITORS

Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...

NEPRILYSIN INHIBITORS

(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...

NEPRILYSIN INHIBITORS

JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease

Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...

CRYSTALLINE(2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENY]-4-YL)-2-(E...

NEPRILYSIN INHIBITORS

NEPRILYSIN INHIBITORS

(2R,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-2-HYDROXY-4-[(5-METHYL...